In 2013, the New England Journal of Medicine reported that two patients with R/R acute lymphoblastic leukemia (ALL) achieved complete remission after receiving anti-CD19 CAR-modified T-cell adoptive transfer therapy. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.